Senate Generic Reform Bill Likely To Result In Earlier ANDA Filings
This article was originally published in The Tan Sheet
Executive Summary
A bipartisan Senate bill would encourage earlier ANDA filings by generics firms to head off new innovator patent listings and secure sole rights to 180-day exclusivity